Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Apr;73(7):909–913. doi: 10.1038/bjc.1996.162

Expression of tropomyosin isoforms in benign and malignant human breast lesions.

B Franzén 1, S Linder 1, K Uryu 1, A A Alaiya 1, T Hirano 1, H Kato 1, G Auer 1
PMCID: PMC2074270  PMID: 8611405

Abstract

High molecular weight tropomyosins (tms) are commonly down-regulated in fibroblasts transformed by oncogenes. Previous studies have also demonstrated that specific tm isoforms are down-regulated in human breast carcinoma cell lines. We examined tropomyosin isoforms in cells prepared from non-cancerous breast lesions and primary human breast carcinomas. The average level of expression of all three high molecular weight tm isoforms (tm 1-3) in carcinomas was generally found to be less than 25% of that observed in non-cancerous breast lesions. Interestingly, the expression of tm 1 was found to be 1.7-fold higher in primary tumours with metastatic spread to axillary lymph nodes compared with primary tumours with no evidence of metastasis (p<0.05). Similarly, tm 1 expression was higher in two 12V-H-ras transformed fibroblast cell lines capable of experimental metastasis compared with three weakly metastatic cell lines. We conclude from these studies that expression of high molecular weight tm isoforms is low in primary breast carcinomas, and that metastatic tumours express relatively high levels of tm 1.

Full text

PDF
909

Images in this article

910Figure 1
on p.910

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhattacharya B., Ciardiello F., Salomon D. S., Cooper H. L. Disordered metabolism of microfilament proteins, tropomyosin and actin, in mouse mammary epithelial cells expressing the Ha-ras oncogene. Oncogene Res. 1988;3(1):51–65. [PubMed] [Google Scholar]
  2. Bhattacharya B., Prasad G. L., Valverius E. M., Salomon D. S., Cooper H. L. Tropomyosins of human mammary epithelial cells: consistent defects of expression in mammary carcinoma cell lines. Cancer Res. 1990 Apr 1;50(7):2105–2112. [PubMed] [Google Scholar]
  3. Cooper H. L., Bhattacharya B., Bassin R. H., Salomon D. S. Suppression of synthesis and utilization of tropomyosin in mouse and rat fibroblasts by transforming growth factor alpha: a pathway in oncogene action. Cancer Res. 1987 Aug 15;47(16):4493–4500. [PubMed] [Google Scholar]
  4. Garrels J. I., Franza B. R., Jr Transformation-sensitive and growth-related changes of protein synthesis in REF52 cells. A two-dimensional gel analysis of SV40-, adenovirus-, and Kirsten murine sarcoma virus-transformed rat cells using the REF52 protein database. J Biol Chem. 1989 Mar 25;264(9):5299–5312. [PubMed] [Google Scholar]
  5. Glück U., Kwiatkowski D. J., Ben-Ze'ev A. Suppression of tumorigenicity in simian virus 40-transformed 3T3 cells transfected with alpha-actinin cDNA. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):383–387. doi: 10.1073/pnas.90.2.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hendricks M., Weintraub H. Tropomyosin is decreased in transformed cells. Proc Natl Acad Sci U S A. 1981 Sep;78(9):5633–5637. doi: 10.1073/pnas.78.9.5633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lees-Miller J. P., Helfman D. M. The molecular basis for tropomyosin isoform diversity. Bioessays. 1991 Sep;13(9):429–437. doi: 10.1002/bies.950130902. [DOI] [PubMed] [Google Scholar]
  8. Matsumura F., Yamashiro-Matsumura S. Purification and characterization of multiple isoforms of tropomyosin from rat cultured cells. J Biol Chem. 1985 Nov 5;260(25):13851–13859. [PubMed] [Google Scholar]
  9. Okuzawa K., Franzén B., Lindholm J., Linder S., Hirano T., Bergman T., Ebihara Y., Kato H., Auer G. Characterization of gene expression in clinical lung cancer materials by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis. 1994 Mar-Apr;15(3-4):382–390. doi: 10.1002/elps.1150150157. [DOI] [PubMed] [Google Scholar]
  10. Prasad G. L., Fuldner R. A., Cooper H. L. Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7039–7043. doi: 10.1073/pnas.90.15.7039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Raz A., Geiger B. Altered organization of cell-substrate contacts and membrane-associated cytoskeleton in tumor cell variants exhibiting different metastatic capabilities. Cancer Res. 1982 Dec;42(12):5183–5190. [PubMed] [Google Scholar]
  12. Takenaga K., Masuda A. Restoration of microfilament bundle organization in v-raf-transformed NRK cells after transduction with tropomyosin 2 cDNA. Cancer Lett. 1994 Nov 25;87(1):47–53. doi: 10.1016/0304-3835(94)90408-1. [DOI] [PubMed] [Google Scholar]
  13. Vandekerckhove J., Bauw G., Vancompernolle K., Honoré B., Celis J. Comparative two-dimensional gel analysis and microsequencing identifies gelsolin as one of the most prominent downregulated markers of transformed human fibroblast and epithelial cells. J Cell Biol. 1990 Jul;111(1):95–102. doi: 10.1083/jcb.111.1.95. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES